Allogene Therapeutics, Inc. (ALLO) Tops Q2 EPS by 6c, beats revenue

Go back to Allogene Therapeutics, Inc. (ALLO) Tops Q2 EPS by 6c, beats revenue
(NASDAQ: ALLO) Delayed: 1.98 -0.09 (4.35%)
Previous Close $2.07    52 Week High
Open $2.13    52 Week Low
Day High $2.16    P/E N/A 
Day Low $1.96    EPS
Volume 6,325,972